Table 2.
Target | Primer (forward/reverse, 5′–3′)a |
---|---|
Protein expression | |
lamB | CTAGCTAGCCATGGTTATGCGCGT/CCCAAGCTTTTACCACCAGGCTTCG |
ail | GGGATCCAGTATTTCTATTGGATATGC/GGTCGACTTAACCCACTTTCACATCATCG |
ompF | GGGATCCTACGGTAAAGTTGACGC/GGTCGACTTAGGACTGAACATAACCCAG |
ompA | GGGATCCGGTTTAGTATGGCGTGC/GGTCGACTTAAGCCTGTGGCTGAGTC |
gp17 | CTAGCTAGCATGGCTAACAAAATTTC/CCCAAGCTTTCAGTTTCGAACTAAG |
gp17(1–469) | CTAGCTAGCATGGCTAACAAAATTTC/CCCAAGCTTTCAATCGACCATCTTG |
gp17(1–119) | CTAGCTAGCATGGCTAACAAAATTTC/CCCAAGCTTTCAAGTATCCGCAG |
gp17(470–569) | CTAGCTAGCGGACTACTCACTACCG/CCCAAGCTTTCAGTTTCGAACTAAG |
Construction of mutants | |
Kanamycin resistance cassette | |
waaA | ATGAATAACCACGGCTCAATGTGGTGCTCCGCCCTCCTAGGTGTAGGCTGGAGCTGCTTC/TTAGTGGCTCCGTTGTGGCAGATAAGGCTCCAACAAATGTCATATGAATATCCTCCTTA |
lamB | ATGATTACTCTGCGCAAGTTACCAATAGCACTGGCTGTTGGTGTAGGCTGGAGCTGCTTC/TTACCACCAGGCTTCGAATTGCGCACCGAAGGTGACTTCACATATGAATATCCTCCTTA |
ail | ATGGTTTTTATGAATAAGACATTACTGGTCTCTTCTTTAAGTGTAGGCTGGAGCTGCTTC/TTAGAACCGGTAACCCGCGCCAAGCATCCAAGTACCCACTCATATGAATATCCTCCTTA |
ompF | ATGAGGGTAATAATAATGATGAAGCGCAATATTCTTGCAGGTGTAGGCTGGAGCTGCTTC/TTAGAACTGGTAAACCAAGCCAACAGCAACAACGTTGTCGCATATGAATATCCTCCTTA |
ompA | TTGCCTATTTGGATGATAATGAGGCGTAAAATGAAAAAGAGTGTAGGCTGGAGCTGCTTC/TTAAGCCTGTGGCTGAGTCACAACTTCTTTGTAGCCTTTCCATATGAATATCCTCCTTA |
Chloromycetin resistance cassette | |
lamB | ATGATTACTCTGCGCAAGTTACCAATAGCACTGGCTGTTGAGATTGCAGCATTACACGTC/TTACCACCAGGCTTCGAATTGCGCACCGAAGGTGACTTCATGTAACGCACTGAGAAGC |
ail | ATGGTTTTTATGAATAAGACATTACTGGTCTCTTCTTTAAAGATTGCAGCATTACACGTC/TTAGAACCGGTAACCCGCGCCAAGCATCCAAGTACCCACTTGTAACGCACTGAGAAGC |
ompF | ATGAGGGTAATAATAATGATGAAGCGCAATATTCTTGCAGAGATTGCAGCATTACACGTC/TTAGAACTGGTAAACCAAGCCAACAGCAACAACGTTGTCGTGTAACGCACTGAGAAGC |
ompA | TTGCCTATTTGGATGATAATGAGGCGTAAAATGAAAAAGAAGATTGCAGCATTACACGTC/TTAAGCCTGTGGCTGAGTCACAACTTCTTTGTAGCCTTTCTGTAACGCACTGAGAAGC |
Gentamicin resistance cassette | |
lamB | ATGATTACTCTGCGCAAGTTACCAATAGCACTGGCTGTTGTTAGGTGGCGGTACTTGGG/TTACCACCAGGCTTCGAATTGCGCACCGAAGGTGACTTCACGTCAGGTGGCACTTTTCG |
ail | ATGGTTTTTATGAATAAGACATTACTGGTCTCTTCTTTAATTAGGTGGCGGTACTTGGG/TTAGAACCGGTAACCCGCGCCAAGCATCCAAGTACCCACTCGTCAGGTGGCACTTTTCG |
ompF | ATGAGGGTAATAATAATGATGAAGCGCAATATTCTTGCAGTTAGGTGGCGGTACTTGGG/TTAGAACTGGTAAACCAAGCCAACAGCAACAACGTTGTCGCGTCAGGTGGCACTTTTCG |
Verification of the mutants | |
waaA | CTGCGGCAGGTTACAAGAAG/ATGTGTGCTAGTCGCAATCC |
lamB | TACTCAAGAAGGTTACTCG/GTTGGCATAAGTTGCGAAG |
ail | ACTGGGGAGTGATAGGTTC/TTACTTCTACTCTCTGATTG |
ompF | CGGCAACGCAACCCGTCTG/CTTCAGAACGGTCATTTTTG |
ompA | GGGTGGTTTAGTATGGCGTG/TCCTGACCAAAGCGGTAAG |
Complementation of mutants | |
lamB | CGCGGATCCGCCCAGAACATC/CCCAAGCTTGTACCAGACAGAGTG |
ompF | CGCGGATCCCCGTTGCGGCGATGGATG/CCCAAGCTTTTTTCAAACATGTCAGAG |
ail | CGCGGATCCCCATTGAGCGTGTGAAAC/CCCAAGCTTCAACTTTACCGTCTCAAC |
ompA | CGCGGATCCTACAGTGTTGTTCTGGG/CCCAAGCTTTACTGAACCCCC |
waaA | CGCGGATCCGTGCAAAAGCCGTAGTC/CCCAAGCTTCGATTTTAAGCTCTGGG |
Underlining indicates endonuclease restriction sites.